Open AccessStudy protocol: Safety and efficacy of smart watch integrated do-it-yourself continuous glucose monitoring in adults with Type 1 diabetes, a randomised controlled trial
Author(s) -
Shekhar Sehgal,
Martin de Bock,
Jonathan Williman,
Barry Taylor,
Mona Elbalshy,
Barbara Galland,
Rosemary M Hall,
Ryan Paul,
Alisa Boucsein,
Stephanie Jones,
Carla M Frewen,
Benjamin J Wheeler
Publication year - 2021
Publication title -
journal of diabetes and metabolic disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.619
H-Index - 33
ISSN - 2251-6581
DOI - 10.1007/s40200-021-00923-y
Subject(s) - medicine , continuous glucose monitoring , diabetes mellitus , crossover study , type 1 diabetes , type 2 diabetes , randomized controlled trial , clinical trial , distress , clinical endpoint , quality of life (healthcare) , blood glucose self monitoring , diabetes management , intensive care medicine , placebo , alternative medicine , nursing , endocrinology , clinical psychology , pathology
Type 1 diabetes (T1D) management requires regular monitoring of glucose levels and judicious therapeutic administration of insulin to prevent both microvascular and macrovascular complications. Few people with diabetes are able to sustain the self-monitored blood glucose measurements needed for optimal care, and those that do, typically experience significant diabetes-related distress. Both intermittently scanned continuous glucose monitoring (isCGM) and continuous glucose monitoring (CGM) offer alternatives to reduce the overall burden, but both still have limitations. Given the expense of CGM, smart watch integrated do-it-yourself (DIY)-CGM has been developed as an alternative to commercial isCGM and CGM technologies. This study has been designed to evaluate the clinical efficacy of smart watch integrated DIY-CGM compared with isCGM in adults with T1D.